Patient growth continues across all regions
Operating margin in North America improved to 18.5% in the third quarter
Dialysis Care revenue growth in North America of 6% (+5% at constant currency)
Decline in Care Coordination revenue following Sound divestiture
Outlook 2018 reflects lower than expected growth acceleration in Q3 and anticipation of soft business development in Q4 2018
Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “Our third quarter
was affected by several developments whose combined impact on our results was greater
than expected. Growth did not accelerate to the extent previously projected. We anticipate the impact from the current level of growth and less acquisitions to continue in the fourth quarter. We have identified countermeasures and have begun implementation.
Fresenius Medical Care’s growth will continue.”
- Fresenius Medical Care
